Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 46.5B | 50.0B | 33.3B | 27.7B |
| Cost of revenue | 11.6B | 14.7B | 10.3B | 8.4B |
| Gross profit | 34.9B | 35.4B | 23.0B | 19.3B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 397.8M | 442.4M | 273.3M | 314.3M |
| Other operating expenses | 3.1B | 4.2B | 2.3B | 2.0B |
| Operating income | 29.4B | 30.1B | 19.1B | 15.6B |
| Non operating interest income | ||||
| Income | 9.3B | 11.6B | 4.4B | 2.0B |
| Expense | 22.7M | -25.1M | 8.4M | 8.2M |
| Other income expense | — | — | — | — |
| Pretax income | 27.4B | 68.9B | 23.7B | 2.6B |
| Tax provision | 10.5B | 8.0B | 14.0B | 5.1B |
| Net income | 16.9B | 60.8B | 9.7B | -2.5B |
| Basic EPS | 4.4 | — | 2.5 | -1.0 |
| Diluted EPS | 4.4 | — | 2.5 | -1.0 |
| Basic average shares | 3.8B | — | 3.8B | 2.5B |
| Diluted average shares | 3.8B | — | 3.8B | 2.5B |
| EBITDA | 10.5B | 16.1B | -39.7M | -24.0B |
| Net income from continuing op. | 16.9B | 60.8B | -631.7M | 23.5B |
| Minority interests | -1.1M | -8.8M | -10.1M | 4.3M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |